Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ixazomib

EU orphan designation number: EU/3/12/1060   
Active ingredient: Ixazomib
Indication: Treatment of systemic light chain amyloidosis
Sponsor: Takeda Pharma A/S
Dybendal Alle 10, 2630 Taastrup, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Orphan designation EMA/OD/110/12 (2012)8193 of 08/11/2012
12/11/2013 Change of name and/or address of sponsor
26/03/2015 Transfer of orphan designation EMA/OD/110/12/T/01 (2015)2047 of 19/03/2015